Analysis of individual and combined effects of ochratoxin a and zearalenone on HepG2 and KK-1 cells with mathematical models

Toxins

Volumn 6, Issue 4, 2014, Pages 1177-1192

  Li, Yuzhe ^a   Zhang, Boyang ^a   He, Xiaoyun ^a   Cheng, Wen Hsing ^b   Xu, Wentao ^a   Luo, Yunbo ^a   Liang, Rui ^a   Luo, Haoshu ^a   Huang, Kunlun ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Combined effect; Concentration addition; Independent addition; Ochratoxin A; Risk assessment; Zearalenone

Indexed keywords

OCHRATOXIN; REACTIVE OXYGEN METABOLITE; ZEARALENONE;

ARTICLE; CELL COUNT; CELL VIABILITY; CYTOTOXICITY; DOSE RESPONSE; ENZYME KINETICS; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN CELL; MATHEMATICAL MODEL; NONLINEAR REGRESSION ANALYSIS; RISK ASSESSMENT; SIMULATION; ANIMAL; BIOLOGICAL MODEL; CELL SURVIVAL; DRUG EFFECTS; FEMALE; HEPG2 CELL LINE; HUMAN; LIVER; METABOLISM; MOUSE; NONLINEAR SYSTEM; OVARY; OXIDATIVE STRESS; PATHOLOGY; TOXICITY;

ANIMALS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEP G2 CELLS; HUMANS; LIVER; MICE; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; OCHRATOXINS; OVARY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RISK ASSESSMENT; ZEARALENONE;

EID: 84897090898     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins6041177     Document Type: Article

References (52)

1. Bennett, J.W.; Klich, M. Mycotoxins. Clin. Microbiol. Rev. 2003, 16, 497-516.
2. Ibaacutentildeez-Vea, M.; Martiacutenez, R.; Gonzaacutelez-Pentildeas, E.; Lizarraga, E.; de Cerain, A.L. Co-occurrence of aflatoxins, ochratoxin A and zearalenone in breakfast cereals from spanish market. Food Control 2011, 22, 1949-1955.
3. Richard, J.L. Some major mycotoxins and their mycotoxicoses-An overview. Int. J. Food Microbiol. 2007, 119, 3-10.
4. Streit, E.; Schatzmayr, G.; Tassis, P.; Tzika, E.; Marin, D.; Taranu, I.; Tabuc, C.; Nicolau, A.; Aprodu, I.; Puel, O.; et al. Current situation of mycotoxin contamination and co-occurrence in animal feed-focus on Europe. Toxins 2012, 4, 788-809.
5. Speijers, G.J.; Speijers, M.H. Combined toxic effects of mycotoxins. Toxicol. Lett. 2004, 153, 91-98.
6. Reddy, L.; Bhoola, K. Ochratoxins-food contaminants: Impact on human health. Toxins 2010, 2, 771-779.
7. Pfohl-Leszkowicz, A.; Manderville, R.A. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51, 61-99.
8. Marin-Kuan, M.; Nestler, S.; Verguet, C.; Bezencon, C.; Piguet, D.; Mansourian, R.; Holzwarth, J.; Grigorov, M.; Delatour, T.; Mantle, P.; et al. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin A carcinogenicity in rat. Toxicol. Sci. 2006, 89, 120-134.
9. Corcuera, L.A.; Arbillaga, L.; Vettorazzi, A.; Azqueta, A.; Lopez de Cerain, A. Ochratoxin Areduces aflatoxin B1 induced DNA damage detected by the comet assay in Hep G2 cells. Food Chem. Toxicol. 2011, 49, 2883-2889.
10. Zheng, J.; Zhang, Y.; Xu, W.; Luo, Y.; Hao, J.; Shen, X.L.; Yang, X.; Li, X.; Huang, K. Zinc protects HepG2 cells against the oxidative damage and DNA damage induced by ochratoxin A. Toxicol. Appl. Pharmacol. 2013, 268, 123-131.
11. Shen, X.L.; Zhang, Y.; Xu, W.; Liang, R.; Zheng, J.; Luo, Y.; Wang, Y.; Huang, K. An iTRAQ-based mitoproteomics approach for profiling the nephrotoxicity mechanisms of ochratoxin A in HEK 293 cells. J. Proteomics 2013, 78, 398-415.
12. Pfohl-Leszkowicz, A.; Manderville, R.A. An update on direct genotoxicity as a molecular mechanism of ochratoxin A carcinogenicity. Chem. Res. Toxicol. 2012, 25, 252-262.
13. Hadjeba-Medjdoub, K.; Tozlovanu, M.; Pfohl-Leszkowicz, A.; Frenette, C.; Paugh, R.J.; Manderville, R.A. Structure-activity relationships imply different mechanisms of action for ochratoxin A-mediated cytotoxicity and genotoxicity. Chem. Res. Toxicol. 2012, 25, 181-190.
14. Ali, R.; Mittelstaedt, R.A.; Shaddock, J.G.; Ding, W.; Bhalli, J.A.; Khan, Q.M.; Heflich, R.H. Comparative analysis of micronuclei and DNA damage induced by Ochratoxin A in two mammalian cell lines. Mutat. Res. 2011, 723, 58-64.
15. Shier, W.T.; Shier, A.C.; Xie, W.; Mirocha, C.J. Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon 2001, 39, 1435-1438.
16. Kuiper, G.G.; Lemmen, J.G.; Carlsson, B.; Corton, J.C.; Safe, S.H.; van der Saag, P.T.; van der Burg, B.; Gustafsson, J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139, 4252-4263.
17. El Golli Bennour, E.; Bouaziz, C.; Ladjimi, M.; Renaud, F.; Bacha, H. Comparative mechanisms of zearalenone and ochratoxin A toxicities on cultured HepG2 cells: Is oxidative stress a common process? Environ. Toxicol. 2009, 24, 538-548.
18. Hassen, W.; Ayed-Boussema, I.; Oscoz, A.A.; Lopez Ade, C.; Bacha, H. The role of oxidative stress in zearalenone-mediated toxicity in Hep G2 cells: Oxidative DNA damage, gluthatione depletion and stress proteins induction. Toxicology 2007, 232, 294-302.
19. El Golli-Bennour, E.; Bacha, H. Hsp70 expression as biomarkers of oxidative stress: Mycotoxins' exploration. Toxicology 2011, 287, 1-7.
20. Eisenbrand, G.; Pool-Zobel, B.; Baker, V.; Balls, M.; Blaauboer, B.J.; Boobis, A.; Carere, A.; Kevekordes, S.; Lhuguenot, J.C.; Pieters, R.; et al. Methods of in vitro toxicology. Food Chem. Toxicol. 2002, 40, 193-236.
21. Lu, S.C.; Huang, H.Y. Comparison of sulfur amino acid utilization for GSH synthesis between HepG2 cells and cultured rat hepatocytes. Biochem. Pharmacol. 1994, 47, 859-869.
22. Urani, C.; Doldi, M.; Crippa, S.; Camatini, M. Human-derived cell lines to study xenobiotic metabolism. Chemosphere 1998, 37, 2785-2795.
23. Bouaziz, C.; Sharaf El Dein, O.; El Golli, E.; Abid-Essefi, S.; Brenner, C.; Lemaire, C.; Bacha, H. Different apoptotic pathways induced by zearalenone, T-2 toxin and ochratoxin A in human hepatoma cells. Toxicology 2008, 254, 19-28.
24. Calabrese, E.J.; Blain, R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: An overview. Toxicol. Appl. Pharmacol. 2005, 202, 289-301.
25. Zhu, L.; Yuan, H.; Guo, C.; Lu, Y.; Deng, S.; Yang, Y.; Wei, Q.; Wen, L.; He, Z. Zearalenone induces apoptosis and necrosis in porcine granulosa cells via a caspase-3-and caspase-9-dependent mitochondrial signaling pathway. J. Cell Physiol. 2012, 227, 1814-1820.
26. Minervini, F.; Giannoccaro, A.; Fornelli, F.; Dell'Aquila, M.E.; Minoia, P.; Visconti, A. Influence of mycotoxin zearalenone and its derivatives (alpha and beta zearalenol) on apoptosis and proliferation of cultured granulosa cells from equine ovaries. Reprod. Biol. Endocrinol. 2006, 4, 62.
27. Calabrese, E.J. Cancer biology and hormesis: Human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit. Rev. Toxicol. 2005, 35, 463-582.
28. Hoffmann, G.R. A perspective on the scientific, philosophical, and policy dimensions of hormesis. Dose Response 2009, 7, 1-51.
29. Mary, V.S.; Theumer, M.G.; Arias, S.L.; Rubinstein, H.R. Reactive oxygen species sources and biomolecular oxidative damage induced by aflatoxin B1 and fumonisin B1 in rat spleen mononuclear cells. Toxicology 2012, 302, 299-307.
30. Heussner, A.H.; Dietrich, D.R.; O'Brien, E. In vitro investigation of individual and combined cytotoxic effects of ochratoxin A and other selected mycotoxins on renal cells. Toxicol. In Vitro 2006, 20, 332-341.
31. Ficheux, A.S.; Sibiril, Y.; Parent-Massin, D. Co-exposure of Fusarium mycotoxins: In vitro myelotoxicity assessment on human hematopoietic progenitors. Toxicon 2012, 60, 1171-1179.
32. Ruiz, M.J.; Macakova, P.; Juan-Garcia, A.; Font, G. Cytotoxic effects of mycotoxin combinations in mammalian kidney cells. Food Chem. Toxicol. 2011, 49, 2718-2724.
33. Greco, W.R.; Bravo, G.; Parsons, J.C. The search for synergy: A critical review from a response surface perspective. Pharmacol. Rev. 1995, 47, 331-385.
34. Backhaus, T.; Faust, M. Predictive environmental risk assessment of chemical mixtures: A conceptual framework. Environ. Sci. Technol. 2012, 46, 2564-2573.
35. Bliss, C.I. The toxicity of poisons applied jointly. Ann. Appl. Biol. 1939, 26, 585-615.
36. Creppy, E.E.; Roschenthaler, R.; Dirheimer, G. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Food Chem. Toxicol. 1984, 22, 883-886.
37. Ringot, D.; Chango, A.; Schneider, Y.J.; Larondelle, Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 2006, 159, 18-46.
38. Creppy, E.E.; Kern, D.; Steyn, P.S.; Vleggaar, R.; Roschenthaler, R.; Dirheimer, G. Comparative study of the effect of ochratoxin A analogues on yeast aminoacyl-tRNA synthetases and on the growth and protein synthesis of hepatoma cells. Toxicol. Lett. 1983, 19, 217-224.
39. Frizzell, C.; Verhaegen, S.; Ropstad, E.; Elliott, C.T.; Connolly, L. Endocrine disrupting effects of ochratoxin A at the level of nuclear receptor activation and steroidogenesis. Toxicol. Lett. 2013, 217, 243-250.
40. Zinedine, A.; Soriano, J.M.; Molto, J.C.; Manes, J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: An oestrogenic mycotoxin. Food Chem. Toxicol. 2007, 45, 1-18.
41. Lioi, M.B.; Santoro, A.; Barbieri, R.; Salzano, S.; Ursini, M.V. Ochratoxin A and zearalenone: A comparative study on genotoxic effects and cell death induced in bovine lymphocytes. Mutat. Res. 2004, 557, 19-27.
42. Mantle, P.G.; Faucet-Marquis, V.; Manderville, R.A.; Squillaci, B.; Pfohl-Leszkowicz, A. Structures of covalent adducts between DNA and ochratoxin A: A new factor in debate about genotoxicity and human risk assessment. Chem. Res. Toxicol. 2010, 23, 89-98.
43. Pfohl-Leszkowicz, A.; Chekir-Ghedira, L.; Bacha, H. Genotoxicity of zearalenone, an estrogenic mycotoxin: DNA adduct formation in female mouse tissues. Carcinogenesis 1995, 16, 2315-2320.
44. Frizzell, C.; Ndossi, D.; Verhaegen, S.; Dahl, E.; Eriksen, G.; Sorlie, M.; Ropstad, E.; Muller, M.; Elliott, C.T.; Connolly, L. Endocrine disrupting effects of zearalenone, alpha and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis. Toxicol. Lett. 2011, 206, 210-217.
45. Gennings, C.; Carter, W.; Campain, J.; Bae, D.-S.; Yang, R.H. Statistical analysis of interactive cytotoxicity in human epidermal keratinocytes following exposure to a mixture of four metals. JABES 2002, 7, 58-73.
46. Jonker, M.J.; Piskiewicz, A.M.; Ivorra i Castella, N.; Kammenga, J.E. Toxicity of binary mixtures of cadmium-copper and carbendazim-copper to the nematode Caenorhabditis elegans. Environ. Toxicol. Chem. 2004, 23, 1529-1537.
47. Hu, Y.; Li, D.M.; Han, X.D. Analysis of combined effects of nonylphenol and Monobutyl phthalate on rat Sertoli cells applying two mathematical models. Food Chem. Toxicol. 2012, 50, 457-463.
48. DeLean, A.; Munson, P.J.; Rodbard, D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 1978, 235, E97-E102.
49. Deng, Z.; Lin, Z.; Zou, X.; Yao, Z.; Tian, D.; Wang, D.; Yin, D. Model of hormesis and its toxicity mechanism based on quorum sensing: A case study on the toxicity of sulfonamides to Photobacterium phosphoreum. Environ. Sci. Technol. 2012, 46, 7746-7754.
50. Loewe, S.; Muischnek, H. Über Kombinationswirkungen, I. Mitteilung: Hilfsmittel der Fragestellung. Naunyn Schmiedebergs. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1926, 114, 313-326.
51. Altenburger, R.; Boedeker, W.; Faust, M.; Grimme, L.H. Regulations for combined effects of pollutants: Consequences from risk assessment in aquatic toxicology. Food Chem. Toxicol. 1996, 34, 1155-1157.
52. Petersen, K.; Tollefsen, K.E. Assessing combined toxicity of estrogen receptor agonists in a primary culture of rainbow trout (Oncorhynchus mykiss) hepatocytes. Aquat. Toxicol. 2011, 101, 186-195.